SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

View Roche Holding AG (RHHBY) current and estimated P/E ratio data provided by Seeking Alpha.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Scholar Rock Holding Corp (SRRK) showcases promising developments in its clinical pipeline, with significant progress in SMA and obesity treatments. GWI research commissioned by Roche (SIX ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...